3006
CN:HYBRIBIO
凯普生物
- Stock
Last Close
6.96
22/11 07:04
Market Cap
3.08B
Beta: -
Volume Today
29.45M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 14.78M - | 19.24M 30.18% | 26.43M 37.40% | 32.02M 21.12% | 33.64M 5.06% | 36.35M 8.08% | 41.81M 15.00% | 69.86M 67.09% | 121.72M 74.24% | 132.94M 9.22% | |
average payables | 11.63M - | 11.11M 4.43% | 21.35M 92.08% | 23.97M 12.30% | 16.86M 29.67% | 21.54M 27.77% | 30.84M 43.17% | 61.06M 97.98% | 153.67M 151.67% | 343.92M 123.80% | |
average receivables | 64.33M - | 90.43M 40.57% | 116.82M 29.18% | 143.26M 22.64% | 186.21M 29.98% | 244.81M 31.47% | 312.68M 27.72% | 471.20M 50.70% | 867.14M 84.03% | 1.95B 124.98% | |
book value per share | 0.48 - | 0.82 72.29% | 0.91 10.64% | 1.08 18.61% | 1.74 61.63% | 1.60 8.18% | 1.83 14.38% | 3.90 113.41% | 4.85 24.43% | 11.18 130.51% | |
capex per share | -0.07 - | -0.19 185.91% | -0.29 50.78% | -0.17 40.59% | -0.12 28.62% | -0.24 96.55% | -0.33 39.22% | -0.47 41.05% | -0.97 107.91% | -1.67 71.91% | |
capex to depreciation | -7.32 - | -9.13 24.61% | -3.18 65.13% | -2.45 23.07% | -4.69 91.78% | -4.77 1.60% | -5.74 20.28% | -7.34 27.99% | -4.11 44.10% | ||
capex to operating cash flow | -1.17 - | -2.30 97.39% | -2.68 16.48% | -1.21 54.67% | -0.85 30.34% | -1.80 112.31% | -1.74 3.04% | -0.92 47.06% | -1.02 10.09% | -0.56 44.76% | |
capex to revenue | -0.15 - | -0.30 106.74% | -0.38 24.77% | -0.19 48.48% | -0.14 27.94% | -0.25 77.97% | -0.27 8.29% | -0.21 21.34% | -0.24 13.14% | -0.13 45.29% | |
cash per share | 0.25 - | 0.26 0.83% | 0.10 59.38% | 0.11 8.63% | 0.31 171.53% | 0.06 80.31% | 0.44 633.07% | 2.04 360.49% | 1.82 10.74% | 3.22 76.69% | |
days of inventory on hand | 166.73 - | 237.86 42.67% | 255.61 7.46% | 222.34 13.02% | 151.00 32.09% | 153.21 1.46% | 111.92 26.95% | 97.44 12.94% | 62.08 36.29% | 25.28 59.28% | |
days payables outstanding | 124.21 - | 112.31 9.58% | 275.55 145.35% | 104.86 61.95% | 80.46 23.27% | 98.17 22.01% | 92.60 5.67% | 87.21 5.82% | 93.30 6.97% | 99.34 6.48% | |
days sales outstanding | 148.64 - | 147.12 1.03% | 134.63 8.49% | 146.01 8.46% | 162.34 11.18% | 173.92 7.13% | 174.55 0.36% | 159.95 8.36% | 155.76 2.62% | 180.06 15.60% | |
debt to assets | 0.15 - | 0.00 98.58% | 0.00 65.60% | 0.02 2,310.70% | 0.00 - | 0.00 51.68% | 0.03 14,633.29% | 0.04 66.08% | 0.02 52.64% | ||
debt to equity | 0.21 - | 0.00 98.88% | 0.00 63.16% | 0.02 2,279.70% | 0.00 - | 0.00 48.06% | 0.03 14,585.69% | 0.06 84.08% | 0.03 50.95% | ||
dividend yield | 0.00 - | 0.00 25.79% | 0.00 - | 0.00 98.74% | 0.01 576,348.87% | 0.01 27.97% | 0.01 37.89% | 0.01 64.74% | 0.02 163.18% | ||
earnings yield | 0.01 - | 0.03 108.16% | 0.03 4.90% | 0.03 16.49% | 0.01 66.44% | 0.03 199.72% | 0.03 4.35% | 0.04 54.63% | 0.10 122.65% | 0.35 254.78% | |
enterprise value | 2.20B - | 2.25B 2.60% | 2.51B 11.12% | 2.51B 0.39% | 9.14B 263.56% | 3.75B 59.02% | 4.89B 30.39% | 7.87B 61.15% | 8.30B 5.49% | 4.05B 51.27% | |
enterprise value over ebitda | 57.76 - | 26.09 54.83% | 27.55 5.59% | 22.50 18.34% | 65.20 189.83% | 23.21 64.40% | 24.36 4.96% | 14.86 38.99% | 6.91 53.49% | 1.39 79.96% | |
ev to operating cash flow | 96.00 - | 65.07 32.22% | 51.69 20.56% | 39.52 23.53% | 115.50 192.22% | 46.61 59.65% | 43.30 7.10% | 25.29 41.59% | 13.15 47.99% | 3.09 76.50% | |
ev to sales | 12.03 - | 8.54 29.01% | 7.27 14.90% | 6.31 13.09% | 19.09 202.26% | 6.46 66.17% | 6.70 3.74% | 5.81 13.22% | 3.11 46.55% | 0.72 76.73% | |
free cash flow per share | -0.01 - | -0.11 1,037.95% | -0.18 67.18% | -0.03 83.25% | 0.02 173.38% | -0.11 579.62% | -0.14 33.75% | 0.04 127.89% | -0.01 137.46% | 1.31 8,965.90% | |
free cash flow yield | -0.00 - | -0.02 1,037.95% | -0.03 67.18% | -0.01 83.25% | 0.00 124.41% | -0.02 1,388.37% | -0.02 3.14% | 0.00 118.14% | -0.00 138.12% | 0.12 10,451.44% | |
graham net net | 0.21 - | 0.38 76.53% | 0.17 54.87% | 0.24 43.38% | 0.45 83.45% | 0.26 42.40% | 0.73 184.26% | 2.32 216.81% | 2.08 10.14% | 4.64 122.92% | |
graham number | 0.88 - | 1.67 89.38% | 1.71 2.58% | 2.01 17.55% | 2.57 27.69% | 2.60 1.22% | 3.20 22.91% | 7.20 125.26% | 11.88 65.00% | 31.44 164.66% | |
income quality | 0.78 - | 0.55 30.42% | 0.75 37.80% | 0.85 13.41% | 0.86 1.09% | 0.75 12.70% | 0.82 9.39% | 0.79 4.26% | 0.71 9.55% | 0.73 1.87% | |
intangibles to total assets | 0.13 - | 0.08 36.65% | 0.07 11.41% | 0.05 24.19% | 0.03 45.66% | 0.03 9.89% | 0.08 206.09% | 0.04 48.45% | 0.03 29.10% | 0.03 10.27% | |
interest coverage | 27.58 - | 68.68 149.06% | 2.64K 3,742.19% | 183.73 93.04% | 5.45K 2,866.02% | 12.13K - | 585.64 95.17% | 145.08 75.23% | 268.01 84.73% | ||
interest debt per share | 0.10 - | 0.00 95.67% | 0.00 80.97% | 0.02 2,635.23% | 0.00 99.84% | 0.00 532.37% | 0.00 78.75% | 0.12 29,907.47% | 0.29 135.69% | 0.34 15.10% | |
inventory turnover | 2.19 - | 1.53 29.91% | 1.43 6.94% | 1.64 14.96% | 2.42 47.25% | 2.38 1.44% | 3.26 36.89% | 3.75 14.86% | 5.88 56.97% | 14.44 145.60% | |
invested capital | 0.21 - | 0.00 98.88% | 0.00 63.16% | 0.02 2,279.70% | 0.00 - | 0.00 48.06% | 0.03 14,585.69% | 0.06 84.08% | 0.03 50.95% | ||
market cap | 2.26B - | 2.36B 4.51% | 2.55B 8.06% | 2.56B 0.17% | 9.33B 264.94% | 3.81B 59.17% | 5.14B 34.99% | 8.19B 59.23% | 8.64B 5.53% | 4.93B 42.93% | |
net current asset value | 106.42M - | 189.28M 77.86% | 125.55M 33.67% | 171.42M 36.53% | 598.51M 249.14% | 601.14M 0.44% | 552.30M 8.12% | 1.64B 196.84% | 1.80B 9.56% | 2.90B 61.24% | |
net debt to ebitda | -1.64 - | -1.24 24.44% | -0.52 58.41% | -0.37 28.17% | -1.32 257.58% | -0.39 70.70% | -1.28 230.31% | -0.60 53.52% | -0.28 52.96% | -0.30 8.11% | |
net income per share | 0.07 - | 0.15 108.16% | 0.14 4.90% | 0.17 16.49% | 0.17 0.88% | 0.19 11.58% | 0.25 32.08% | 0.59 137.77% | 1.29 118.80% | 3.93 203.87% | |
operating cash flow per share | 0.06 - | 0.08 44.85% | 0.11 29.44% | 0.14 31.06% | 0.14 2.47% | 0.13 7.42% | 0.19 43.58% | 0.51 166.43% | 0.96 88.85% | 2.98 211.20% | |
payables turnover | 2.94 - | 3.25 10.60% | 1.32 59.24% | 3.48 162.78% | 4.54 30.32% | 3.72 18.04% | 3.94 6.01% | 4.19 6.18% | 3.91 6.52% | 3.67 6.09% | |
receivables turnover | 2.46 - | 2.48 1.04% | 2.71 9.28% | 2.50 7.80% | 2.25 10.06% | 2.10 6.66% | 2.09 0.36% | 2.28 9.13% | 2.34 2.69% | 2.03 13.49% | |
research and ddevelopement to revenue | 0.07 - | 0.09 36.30% | 0.08 12.43% | 0.07 12.46% | 0.08 13.03% | 0.08 0.53% | 0.05 32.86% | 0.04 18.43% | 0.04 2.43% | ||
return on tangible assets | 0.12 - | 0.18 45.18% | 0.14 20.54% | 0.14 2.31% | 0.09 35.36% | 0.10 9.85% | 0.12 25.28% | 0.13 7.22% | 0.21 56.67% | 0.26 27.68% | |
revenue per share | 0.45 - | 0.63 38.29% | 0.76 20.84% | 0.88 15.32% | 0.87 0.94% | 0.96 10.44% | 1.23 28.57% | 2.21 79.33% | 4.06 83.76% | 12.75 214.23% | |
roe | 0.15 - | 0.18 20.82% | 0.16 14.05% | 0.16 1.78% | 0.10 37.58% | 0.12 21.52% | 0.14 15.47% | 0.15 11.42% | 0.27 75.84% | 0.35 31.82% | |
roic | 0.13 - | 0.18 44.07% | 0.15 16.69% | 0.14 6.72% | 0.10 32.10% | 0.11 14.96% | 0.13 15.96% | 0.16 26.35% | 0.26 63.15% | 0.37 38.61% | |
sales general and administrative to revenue | 0.24 - | 0.06 75.77% | 0.06 4.57% | 0.05 6.72% | 0.08 55.58% | 0.09 7.01% | 0.08 10.98% | 0.05 35.75% | 0.03 33.15% | 0.03 22.98% | |
shareholders equity per share | 0.48 - | 0.82 72.29% | 0.91 10.64% | 1.08 18.61% | 1.74 61.63% | 1.60 8.18% | 1.83 14.38% | 3.90 113.41% | 4.85 24.43% | 11.18 130.51% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 157.11M - | 313.70M 99.67% | 378.66M 20.71% | 470.51M 24.25% | 939.63M 99.71% | 1.05B 11.62% | 1.08B 2.98% | 2.42B 123.65% | 3.35B 38.70% | 5.01B 49.48% | |
tangible book value per share | 0.39 - | 0.75 91.06% | 0.83 11.70% | 1.03 24.05% | 1.70 64.48% | 1.73 1.76% | 1.82 5.35% | 3.94 115.97% | 5.08 29.15% | 11.41 124.33% | |
working capital | 118.13M - | 190.69M 61.42% | 145.34M 23.78% | 188.28M 29.55% | 612.73M 225.43% | 612.87M 0.02% | 558.41M 8.89% | 1.66B 197.11% | 1.87B 13.01% | 3.04B 62.01% |
All numbers in (except ratios and percentages)